SARS-CoV-2 vaccine humoral response in adults with Down syndrome

OBJECTIVE: People with Down syndrome (DS) are particularly vulnerable to coronavirus disease 2019 (COVID-19) and show altered immune response to vaccination. We aimed to evaluate the immune response of a group of adults with DS treated with standard regimens of SARS-CoV-2 vaccine as compared with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sali, Michela, Carfì, Angelo, Di Paola, Antonella, Pereyra Boza, Maria, Zampino, Giuseppe, Sanguinetti, Maurizio, Landi, Francesco, Onder, Graziano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022372/
https://www.ncbi.nlm.nih.gov/pubmed/35461998
http://dx.doi.org/10.1016/j.cmi.2022.04.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022372/
https://www.ncbi.nlm.nih.gov/pubmed/35461998
http://dx.doi.org/10.1016/j.cmi.2022.04.008

Ejemplares similares